Pharmaceutical News
Boehringer Licenses Viral Vector Platform
Boehringer Ingelheim has taken a decisive step in advancing next-generation cancer therapeutics by securing an exclusive licensing agreement for a…
#immuno-oncology
More articles
Oncology / Cancer Immunotherapy
Personalized mRNA Cancer Vaccines
The landscape of oncology is witnessing a paradigm shift, moving away from the one-size-fits-all approach of conventional chemotherapy towards more…